Last reviewed · How we verify

NCT05128006

Direct-to-patient Teledermatology and Computer-assisted Diagnosis

Recruiting now Last updated 23 January 2026
What this trial tests

trial testing New patient teledermatology visit in New Patient Use of Teledermatology Mobile App in 63,200 participants. Currently enrolling.

Timeline
7 November 2022
Primary endpoint
30 June 2026
30 September 2026

Quick facts

Lead sponsorVA Office of Research and Development
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment63,200
Start date7 November 2022
Primary completion30 June 2026
Estimated completion30 September 2026
Sites3 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

VA Office of Research and Development — full company profile →

Who can join

18 and older, any sex, with New Patient Use of Teledermatology Mobile App. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will examine access to dermatology care. The operational partner will implement a direct-to-new patient teledermatology clinical care pathway while the research will study the effects of that implementation, use data associated with deployment to develop and test an Artificial Intelligence system, and understand key stakeholders' attitudes regarding and readiness for remote dermatology care.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other VA Office of Research and Development trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05128006.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing